Related Experiment Video
Updated: May 13, 2026

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells
Published on: December 13, 2016
Toxicity of magnetic resonance imaging agents: small molecule and nanoparticle
Yongmin Chang1, Gang Ho Lee, Tae-Jeong Kim
1Department of Molecular Medicine and Radiology, College of Medicine, Kyungpook National University, Daegu 702-701, South Korea.
Abstract:
Magnetic resonance imaging (MRI) contrast agents have been used routinely for more than 20 years in order to increase sensitivity and specificity of lesion detection. MRI contrast agents (CAs) are usually categorized according to their magnetic behavior, biodistribution, and effect on the MR image. Typically, small molecular-weight gadolinium based CAs are examples of T1 agents, while magnetic nanoparticle (MNP) based CAs are examples of T2 agents. In addition to differences in magnetic relaxation behavior, small molecular-weight gadolinium based CAs and MNP based CAs show significantly different toxicity profiles. In the case of small molecular-weight gadolinium based CAs, many previous toxicological studies have reported favorable safety profiles of gadolinium based CAs. However, recently, a delayed serious adverse reaction known as nephrogenic systemic fibrosis (NSF) has been reported in patients, with a marked reduction in renal function after administration of certain types of gadolinium based CAs. For MNP based CAs, in addition to a wide spectrum of nanotoxicity common in nanomaterials, the emerging unexpected cytotoxicity of MNPs has become a new concern. Specifically, the combination of MNPs and strong static magnetic field (SMF) within MRI may give rise to potential adverse effects of MNPs in clinical application.
Insights
Magnetic resonance imaging (MRI) contrast agents, including gadolinium-based and magnetic nanoparticle (MNP) types, have different toxicity profiles. Recent concerns highlight potential risks with both, necessitating careful safety evaluation for clinical use.
Area of Science:
- Medical Imaging
- Nanotechnology
- Toxicology
Background:
- MRI contrast agents enhance lesion detection, categorized by magnetic behavior and biodistribution.
- Gadolinium-based agents are T1 agents; magnetic nanoparticle (MNP) agents are T2 agents.
- Both agent types exhibit distinct toxicity profiles requiring careful consideration.
Purpose of the Study:
- To compare the safety profiles of gadolinium-based and MNP-based MRI contrast agents.
- To highlight emerging toxicity concerns associated with both agent types.
- To inform clinical application and future development of MRI contrast agents.
Main Methods:
- Review of toxicological studies on gadolinium-based contrast agents.
- Analysis of nanotoxicity and cytotoxicity data for MNP-based contrast agents.
- Consideration of MNP interactions with static magnetic fields in MRI.
Main Results:
- Gadolinium-based agents, while generally safe, are linked to nephrogenic systemic fibrosis (NSF) in patients with reduced renal function.
- MNP-based agents present general nanotoxicity risks and specific concerns regarding unexpected cytotoxicity.
- The combination of MNPs and MRI's static magnetic fields may pose additional clinical risks.
Conclusions:
- Both gadolinium-based and MNP-based contrast agents require ongoing safety assessment.
- Emerging adverse effects, including NSF and MNP cytotoxicity, necessitate further research.
- Understanding these risks is crucial for the safe clinical implementation of MRI contrast agents.
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Drug Toxicity: Dose-Dependent Reactions
Imaging Studies for Cardiovascular System IV: CMRI
Nuclear Magnetic Resonance (NMR): Overview
NMR spectroscopy generates a spectrum where the characteristic absorption frequencies of the sample are...
Imaging Studies IV: Magnetic Resonance Imaging

